Multispecific antigen binding proteins
OwnerLaurent GAUTHIER, Benjamin ROSSIinventors
Life of this patent
Estimating the term…
Abstract
Multimeric multispecific proteins formed from dimerization between CH1 and CK domains and that bind two target antigens are provided. The proteins have advantages in production and in the treatment of disease, notably cancer or infectious disease.
Claims21
1-50. (canceled)
A multispecific protein comprising a first and a second polypeptide chain each comprising a variable domain fused to a CH1 or Cκ domain (a V-(CH1/Cκ) unit), in turn fused at its C-terminus to a human Fc domain, wherein the V-(CH1/Cκ) unit of the first chain is bound, by CH1-Cκ dimerization, to the V-(CH1/Cκ) unit of the second chain thereby foaming a first antigen binding domain and a dimeric Fc domain, wherein one of the polypeptide chains further comprises an antigen binding domain that forms a second antigen binding domain, and wherein the Fc domain comprises N-linked glycosylation at residue N297 (Kabat EU numbering) and binds to a human CD16 polypeptide.
A multispecific protein comprising three polypeptide chains, each comprise a variable domain fused to a CH1 or Cκ domain (a V-(CH1/Cκ) unit), wherein a first (central) chain comprises two V-(CH1/Cκ) units and a human Fc domain interposed between the units, the second chain comprises one V-(CH1/Cκ) unit and a human Fc domain, and the third chain comprises one V-(CH1/Cκ) unit, wherein one of the V-(CH1/Cκ) units of the central chain is bound, by CH1-Cκ dimerization, to the V-(CH1/Cκ) unit of the second chain thereby forming a first antigen binding domain and a dimeric Fc domain, and wherein the other of the V-(CH1/Cκ) units of the central chain is bound, by CH1-Cκ dimerization, to the V-(CH1/Cκ) unit of the third chain thereby forming a second antigen binding domain, and wherein the Fc domain comprises N-linked glycosylation at residue N297 (Kabat EU numbering) and binds to a human CD16 polypeptide.
A multispecific protein that binds to three antigens of interest and to a human CD16 polypeptide, the protein comprising three polypeptide chains that each comprise a variable domain fused to a CH1 or Cκ domain (a V-(CH1/Cκ) unit), wherein a first (central) chain comprises, from N- to C-terminus, a first V-(CH1/Cκ) unit, a human Fc domain and a second V-(CH1/Cκ) unit, and a second chain comprise from N- to C-terminus a first V-(CH1/Cκ) unit and a human Fc domain, and a third chain comprises a V-(CH1/Cκ) unit, and wherein the first V-(CH1/Cκ) unit of the central chain is bound, by CH1-Cκ dimerization, to the V-(CH1/Cκ) unit of the second chain thereby forming a first antigen binding domain and a dimeric Fc domain, wherein the second V-(CH1/Cκ) unit of the central chain is bound, by CH1-Cκ dimerization, to the V-(CH1/Cκ) unit of the third chain thereby forming a second antigen binding domain, and wherein the third polypeptide chain further comprises an antigen binding domain that forms a third antigen binding domain.
The protein of claim 2, wherein the multispecific protein is a trimer with a dimeric Fc domain, having the domain arrangement:
- wherein one V1 is a light chain variable domain and the other VI is a heavy chain variable domain, wherein one V2 is a light chain variable domain and the other V2 is a heavy chain variable domain, wherein the V1 pair will form a first ABD, and the V2 pair will form a second ABD.
Dependencies are inferred from the claim text.